More Post from the Author
- NEW ONLINE TOOL HELPS TEENS TAKE CHARGE OF THEIR MENTAL HEALTH
- BayCare Breaks Ground on BayCare Hospital Manatee and BayCare HealthHub (Manatee)
- Genomma Lab Internacional Announces Results for the First Quarter 2025
- Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi (Dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine
- PHARMA AI COUNCIL (PAC) STARTET ZUR BESCHLEUNIGUNG DER INNOVATION UND DES VERANTWORTUNGSVOLLEN EINSATZES DER KOGNITIVEN TECHNIK IN DEN BIOWISSENSCHAFTEN
InventHelp Inventor Develops New Accessory for Bottle-Fed Babies (CHK-2090)

PITTSBURGH, March 13, 2025 /PRNewswire/ -- "I wanted to create a product to help prevent bottle milk or other fluids from flowing into a baby's ear canals when drinking in a back-lying, side-lying, or reclined position," said an inventor, fromWaukegan, Ill., "so I invented THE FLUID EAR CATCHER. My design would provide added safety, comfort and convenience when bottle-feeding a baby."
The invention provides an effective way to prevent liquids from baby bottles from flowing into a baby's ears when they are in a reclined position. In doing so, it could help prevent potential ear infections. It also provides added protection and peace of mind. The invention features a practical design that is easy to use so it is ideal for parents and caregivers of bottle-fed infants, childcare facilities, etc. Additionally, a prototype is available.
The original design was submitted to the Chicago sales office ofInventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 23-CHK-2090, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
SOURCE InventHelp

More Post from the Author
- NEW ONLINE TOOL HELPS TEENS TAKE CHARGE OF THEIR MENTAL HEALTH
- BayCare Breaks Ground on BayCare Hospital Manatee and BayCare HealthHub (Manatee)
- Genomma Lab Internacional Announces Results for the First Quarter 2025
- Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi (Dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine
- PHARMA AI COUNCIL (PAC) STARTET ZUR BESCHLEUNIGUNG DER INNOVATION UND DES VERANTWORTUNGSVOLLEN EINSATZES DER KOGNITIVEN TECHNIK IN DEN BIOWISSENSCHAFTEN